Nordimet (Methotrexate)

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for making tetrahydrofolate, a cofactor for DNA and RNA synthesis. By limiting nucleotide production, it suppresses the activity of rapidly dividing immune cells such as activated T‑lymphocytes, leading to reduced inflammation and immune‑mediated tissue damage.

The dose of Nordimet is individualized by the prescribing clinician based on the specific indication, disease severity, renal and hepatic function, and patient tolerance. Only a qualified health‑care professional should determine the appropriate dosing regimen and any adjustments over time.

Nordimet is classified as pregnancy category X, meaning it is contraindicated in pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as methotrexate can be excreted in breast milk and may affect the infant. Effective contraception is required for women of child‑bearing potential.

To request Nordimet, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Nordimet (methotrexate) is a conventional synthetic DMARD that is generally less expensive than biologic agents and has a long history of use. It is often used as first‑line therapy or in combination with biologics to enhance efficacy. While biologics target specific cytokines, methotrexate provides broader immunosuppression, which may be advantageous in certain patient populations.

Nordimet should be stored at 2‑8 °C (refrigerated). Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the vial. If temporary storage at room temperature is unavoidable, limit exposure to less than 24 hours and return it to refrigeration promptly.

Nordimet is supplied as a sterile solution for subcutaneous injection. A health‑care professional or trained patient administers the dose using a pre‑filled syringe or autoinjector, typically into the abdomen or thigh. Injection technique, site rotation and proper aseptic handling are essential to minimize local reactions and ensure accurate dosing.

The most serious adverse events include severe liver toxicity, bone‑marrow suppression leading to pancytopenia, and life‑threatening infections such as pneumonia or opportunistic fungal infections. Pulmonary fibrosis and severe cutaneous reactions are also rare but critical. Regular monitoring of liver enzymes, blood counts and respiratory status helps detect these risks early.

Nordimet is contraindicated in pregnant women, individuals with known hypersensitivity to methotrexate, patients with severe hepatic impairment, and those with significant renal dysfunction (creatinine clearance <30 mL/min). It should also be avoided in patients with active, uncontrolled infections or those receiving live vaccines.